SciELO Analytics (Beta)
Colombia
Biomédica (0120-4157)
Incidencia y factores asociados al abandono del tratamiento antituberculoso

Received Citations (9)

publishing year previous first author document title
2015 Revista de Saúde Pública Herrero, María Belén Análisis espacial del abandono del tratamiento de tuberculosis, Buenos Aires, Argentina
2013 Revista de la Universidad Industrial de Santander. Salud Orozco Vargas, Luis Carlos Associated factors with irregular intake of Dapsone in leprosy patients
2010 Cogitare Enfermagem Giroti, Suellen Karina de Oliveira Profile of patients with tuberculosis and factors related to the treatmentabandonment
2017 Avances en Enfermería Martínez Gutiérrez, Alfonsina del Cristo Clinical and therapeutic characterization of patients with pulmonary tuberculosis in Cali
2013 Revista americana de medicina respiratoria Bisero, Elsa Evaluación de adherencia al tratamiento en un nuevo modelo de atención de niños con tuberculosis en un hospital público
2013 Revista americana de medicina respiratoria Bisero, Elsa Evaluación de adherencia al tratamiento en un nuevo modelo de atención de niños con tuberculosis en un hospital público
2016 Biomédica Dueñes, Magally Factors related to treatment adherence in patients with tuberculosis in Pereira, Colombia, 2012-2013
2015 Revista Brasileira de Epidemiologia Herrero, María Belén Determinantes da não adesão ao tratamento da tuberculose na Argentina: barreiras relacionadas com o acesso ao tratamento
2017 Revista Gerencia y Políticas de Salud Carvajal-Barona, Rocío Obstacles Associated with the Adherence to Tuberculosis Treatment in Cali and Buenaventura, Colombia, 2012
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.